Tim Watts, CFO at Shield Therapeutics #STX presenting at our Life Sciences Investor Briefing Watch Now

Pin to quick picksANGLE Regulatory News (AGL)

Share Price Information for ANGLE (AGL)

London Stock Exchange
Share Price: 82.50
Bid: 82.00
Ask: 83.00
Change: 1.50 (1.85%)
Spread: 1.00 (1.22%)
Open: 81.00
High: 83.50
Low: 81.00
Yest. Close: 81.00
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Date   Source Headline
13th Sep 20197:00 amRNSAngle PLC - Use of Parsortix in head and neck cancer
10th Sep 20197:00 amRNSAngle PLC - Research with Parsortix in prostate cancer
4th Sep 20197:00 amRNSAngle PLC - Parsortix for Neuroendocrine Analysis in SCLC
29th Aug 20197:00 amRNSAngle PLC - Initiation of Ovarian Cancer Study
31st Jul 20197:00 amRNSAngle PLC - Prelim Results for the year ended 30 April 2019
22nd Jul 20197:00 amRNSAngle PLC - Use of Parsortix for single cell analysis of CTCs
16th Jul 20199:19 amRNSAngle PLC - Holding(s) in Company
12th Jul 201910:22 amRNSAngle PLC - Result of General Meeting anf Total Voting Rights
28th Jun 20191:37 pmRNSAngle PLC - Notice of Preliminary Results and Webcast
28th Jun 20191:08 pmRNSAngle PLC - Holding(s) in Company
25th Jun 20195:19 pmRNSAngle PLC - Result of Placing
25th Jun 20198:02 amRNSAngle PLC - Accelerated bookbuild to raise £18.0m
21st Jun 20197:00 amRNSAngle PLC - Parsortix used to investigate immunotherapy target
5th Jun 20197:00 amRNSAngle PLC - Completion of Ovarian Cancer Pre-Study
31st May 20197:00 amRNSAngle PLC - Positive Results from FDA Clinical Study
26th Apr 20197:00 amRNSAngle PLC - IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS
18th Apr 20197:00 amRNSAngle PLC - Parsortix used in new cancer assessment technique
12th Apr 20197:00 amRNSAngle PLC - LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM
4th Apr 20197:00 amRNSAngle PLC - AACR 2019
11th Mar 20197:00 amRNSAngle PLC - Holding(s) in Company
7th Mar 20197:00 amRNSAngle PLC - ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
28th Feb 20197:00 amRNSAngle PLC - FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
25th Feb 20197:00 amRNSAngle PLC - CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX
11th Feb 20197:00 amRNSAngle PLC - Research into role of immune cells in cancer
31st Jan 20197:00 amRNSAngle PLC - Interim Results
29th Jan 20197:00 amRNSAngle PLC - NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS
11th Jan 20192:05 pmRNSAngle PLC - Second Price Monitoring Extn
11th Jan 20192:00 pmRNSAngle PLC - Price Monitoring Extension
11th Jan 201911:05 amRNSAngle PLC - Second Price Monitoring Extn
11th Jan 201911:00 amRNSAngle PLC - Price Monitoring Extension
11th Jan 20199:05 amRNSAngle PLC - Second Price Monitoring Extn
11th Jan 20199:00 amRNSAngle PLC - Price Monitoring Extension
10th Jan 20194:41 pmRNSAngle PLC - Second Price Monitoring Extn
10th Jan 20194:36 pmRNSAngle PLC - Price Monitoring Extension
10th Jan 20194:01 pmRNSAngle PLC - BREAKTHROUGH CANCER RESEARCH USING PARSORTIX
9th Jan 20197:00 amRNSAngle PLC - Notice of Results
28th Nov 20187:00 amRNSAngle PLC - LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR
5th Nov 20187:00 amRNSAngle PLC - Acquisition of outstanding shares
2nd Nov 20182:00 pmRNSAngle PLC - Price Monitoring Extension
30th Oct 20184:21 pmRNSAngle PLC - Result of AGM
28th Aug 20187:00 amRNSAngle PLC - Parsortix shows evidence of CTCs in glioblastoma
25th Jul 20187:00 amRNSAngle PLC - Preliminary Results for year ended 30 April 2018
24th Jul 20185:42 pmRNSAngle PLC - EIS/VCT Advance Assurance and Total Voting Rights
4th Jun 20187:00 amRNSAngle PLC - ENCOURAGING PROGRESS IN ANG-002 FDA CLINICAL STUDY
19th Apr 20187:00 amRNSAngle PLC - Breakthrough Research with Parsortix
26th Mar 20184:35 pmRNSAngle PLC - Price Monitoring Extension
26th Mar 20187:00 amRNSAngle PLC - Research Update
6th Feb 20187:00 amRNSANGLE plc: RESEARCH GRANT FROM ABBOTT
31st Jan 20187:00 amRNSInterim Results
27th Dec 201711:49 amRNSHolding(s) in Company

Login to your account

Don't have an account? Click here to register.